A new PPARα/γ co-agonist for the treatment of dyslipidemia

被引：0
|
作者：
Clay, C [1 ]
Tigon, X [1 ]
Ding, S [1 ]
Braileanu, G [1 ]
Hansen, B [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2004年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [21] Co-treatment with retinyl retinoate and a PPARα agonist reduces retinoid dermatitis
    Kim, Bora
    Kim, Jin E.
    Kim, Hyuk
    Lee, Joo D.
    Choi, Kang-Yell
    Lee, Seung H.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (06) : 733 - 741
  • [22] d-Serine, the Shape-Shifting NMDA Receptor Co-agonist
    Joseph T. Coyle
    Darrick Balu
    Herman Wolosker
    Neurochemical Research, 2020, 45 : 1344 - 1353
  • [23] d-Serine, the Shape-Shifting NMDA Receptor Co-agonist
    Coyle, Joseph T.
    Balu, Darrick
    Wolosker, Herman
    NEUROCHEMICAL RESEARCH, 2020, 45 (06) : 1344 - 1353
  • [24] A Novel Glucagon/GLP-1 Co-Agonist Eliminates Obesity in Rodents
    Tschoep, Matthias H.
    Ottaway, Nickki
    Perez-Tilve, Diego
    Pfluger, Paul T.
    Nogueiras, Ruben
    Chaudhary, Nilika
    Holland, Jenna
    Hembree, Jazzminn
    Abplanalp, William
    Grant, Erin
    Ruehl, Jennifer
    Wilson, Hilary
    Kirchner, Henriette
    Lockie, Sarah
    Hofmann, Susanna
    Findeisen, Hannes
    Bruemmer, Dennis
    Gidda, Jas
    Day, Jon
    Smiley, David
    Gelfanov, Vasily
    Dimarchi, Richard
    DIABETES, 2009, 58 : A83 - A83
  • [25] Improved insulin sensitivity and dyslipidemia following oral administration of combination PPARγ/α, and PPARδ agonist in obese rhesus monkeys
    Lewis, MC
    Winegar, DA
    Bodkin, NL
    Hansen, BC
    Oliver, WR
    DIABETES, 2002, 51 : A140 - A140
  • [26] Co-administration of PPARγ, α, and δ agonist, improves efficacy relative to PPARγ agonist alone in ZDF rats
    Lewis, MC
    Wilson, JG
    Franklin, MC
    Brown, JG
    Strole, CA
    Oliver, WR
    Winegar, DA
    DIABETES, 2002, 51 : A140 - A140
  • [27] D-serine acts as a Co-agonist at NMDA receptors in the vertebrate retina
    Stevens, ER
    Doerr, TA
    Kim, P
    Miller, RF
    Snyder, SH
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1343 - U1343
  • [28] Application of the Co-Agonist Concerted Transition Model to Analysis to GABAA Receptor Properties
    Germann, Allison L.
    Steinbach, Joe Henry
    Akk, Gustav
    CURRENT NEUROPHARMACOLOGY, 2019, 17 (09) : 843 - 851
  • [29] PPARγ AGONIST PIOGLITAZONE IN THE MANAGEMENT OF SEVERE DYSLIPIDEMIA IN A PATIENT WITH GLYCOGENOSIS TYPE 1A
    Gautschi, M.
    Christ, E.
    Salvisberg, C.
    Zuercher, T.
    Schuetz, B.
    Nuoffer, J. M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S175 - S175
  • [30] The PPARα/γ dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats
    Li, Ping-Ping
    Shan, Song
    Chen, Yue-Teng
    Ning, Zhi-Qiang
    Sun, Su-Juan
    Liu, Quan
    Lu, Xian-Ping
    Xie, Ming-Zhi
    Shen, Zhu-Fang
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (05) : 610 - 618
12345